Physician profile
John D Steffens
NPI 1871683409
$13,207.07
in general payments reported to CMS, 2019-2025
53 companies · $1,573 in 2025
The $1,573 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,747 · 2020: $1,285 · 2021: $1,994 · 2022: $2,295 · 2023: $2,183 · 2024: $2,129 · 2025: $1,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,871 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,871.05 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,721.02 | 2021-2025 | Ubrelvy, Qulipta |
| Emd Serono, INC. | $2,024.93 | 2019-2025 | Mavenclad |
| Ucb, INC. | $673.99 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Acadia Pharmaceuticals INC | $569.71 | 2019-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $566.12 | 2019-2025 | |
| Sk Life Science, INC. | $483.03 | 2020-2025 | Xcopri |
| Celgene Corporation | $473.92 | 2021-2025 | Zeposia |
| Biogen, INC. | $448.80 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Livanova USA, INC. | $424.96 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Abbott Laboratories | $420.81 | 2019-2023 | Infinity |
| Boston Scientific Corporation | $348.18 | 2019-2023 | Vercise |
| Amneal Pharmaceuticals LLC | $325.67 | 2019-2023 | Rytary |
| Lilly USA, LLC | $293.73 | 2019-2024 | Emgality, Reyvow, Amyvid |
| Supernus Pharmaceuticals, INC. | $251.49 | 2019-2021 | |
| Csl Behring | $250.62 | 2019-2023 | Hizentra |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Steffens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.